AR105005A1 - Derivados de pirrolotriazinona como inhibidores de pi3k - Google Patents

Derivados de pirrolotriazinona como inhibidores de pi3k

Info

Publication number
AR105005A1
AR105005A1 ARP160101778A ARP160101778A AR105005A1 AR 105005 A1 AR105005 A1 AR 105005A1 AR P160101778 A ARP160101778 A AR P160101778A AR P160101778 A ARP160101778 A AR P160101778A AR 105005 A1 AR105005 A1 AR 105005A1
Authority
AR
Argentina
Prior art keywords
group
branched
linear
hydrogen atom
independently represents
Prior art date
Application number
ARP160101778A
Other languages
English (en)
Inventor
Pilar Forns Berenguel Maria
Mir Cepeda Marta
Taltavull Moll Joan
Erra Sola Montserrat
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of AR105005A1 publication Critical patent/AR105005A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen derivados de pirrolotriazinona; así como procedimientos para su preparación, composiciones farmacéuticas que los comprenden y su uso en terapia como inhibidores de fosfoinositida-3-quinasas (PI3Ks). Reivindicación 1: Un compuesto de fórmula (1), o una de sus sales farmacéuticamente aceptables, o N-óxido, o derivado marcado con isótopo, en donde, n representa un número entero seleccionado de 1 ó 2; X e Y representa cada uno independientemente un átomo de nitrógeno o grupo CR³; R¹ y R² representa cada uno independientemente un átomo de hidrógeno o un grupo alquilo C₁₋₄ lineal o ramificado; R³ representa un átomo de hidrógeno, un átomo de halógeno, un hidroxilo, un grupo alquilo C₁₋₄ lineal o ramificado, un grupo C₁₋₄ alcoxi o un grupo halógenoalquilo C₁₋₄; Z representa un grupo -CH((CH₂)₀₋₁-NRᵃRᵇ)-, un grupo -NH- o un grupo -N(alquilo C₁₋₃)-; Rᵃ y Rᵇ representa cada uno independientemente un átomo de hidrógeno o un grupo alquilo C₁₋₄ lineal o ramificado; o Rᵃ y Rᵇ junto con el átomo de nitrógeno al que están unidos forman un grupo heterociclilo de 3 a 7 miembros, monocíclico, que contiene opcionalmente al menos un heteroátomo adicional seleccionado de O, S y N.
ARP160101778A 2015-06-16 2016-06-15 Derivados de pirrolotriazinona como inhibidores de pi3k AR105005A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15382317 2015-06-16

Publications (1)

Publication Number Publication Date
AR105005A1 true AR105005A1 (es) 2017-08-30

Family

ID=53496611

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101778A AR105005A1 (es) 2015-06-16 2016-06-15 Derivados de pirrolotriazinona como inhibidores de pi3k

Country Status (3)

Country Link
AR (1) AR105005A1 (es)
TW (1) TW201710270A (es)
WO (1) WO2016202800A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112028892B (zh) * 2020-07-29 2022-12-16 天津全和诚科技有限责任公司 4-氨基-吡咯并三嗪衍生物在制备抗肺纤维化制剂中的应用
CN112920203A (zh) * 2021-01-26 2021-06-08 浙江永太科技股份有限公司 一种瑞德西韦有关物质及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7920688V0 (it) 1979-02-05 1979-02-05 Chiesi Paolo Parma Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore.
CY1492A (en) 1981-07-08 1990-02-16 Draco Ab Powder inhalator
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FI69963C (fi) 1984-10-04 1986-09-12 Orion Yhtymae Oy Doseringsanordning
DE3927170A1 (de) 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
IT1237118B (it) 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
WO1992003175A1 (en) 1990-08-11 1992-03-05 Fisons Plc Inhalation device
DE4027391A1 (de) 1990-08-30 1992-03-12 Boehringer Ingelheim Kg Treibgasfreies inhalationsgeraet
DE69132850T2 (de) 1990-09-26 2002-05-29 Pharmachemie B.V., Haarlem Wirbelkammer-Pulverinhalator
GB9026025D0 (en) 1990-11-29 1991-01-16 Boehringer Ingelheim Kg Inhalation device
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
DE4239402A1 (de) 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
AU683036B2 (en) 1992-12-18 1997-10-30 Merck Sharp & Dohme Corp. Inhaler for powdered medications
PL182198B1 (en) 1995-06-21 2001-11-30 Asta Medica Ag Pharmaceutic powder holding container with integrated measuring device and powdered
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
CN1997418B (zh) 2004-07-16 2010-08-11 奥米罗有限公司 用于粉状药物给药的吸入器,以及用于与该吸入器一起使用的药粉筒系统
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
PE20150637A1 (es) 2012-10-16 2015-05-08 Almirall Sa Derivados de pirrolotriazinona como inhibidores de pi3k

Also Published As

Publication number Publication date
WO2016202800A1 (en) 2016-12-22
TW201710270A (zh) 2017-03-16

Similar Documents

Publication Publication Date Title
CY1124726T1 (el) Παραγωγα κιναζολινης που χρησιμοποιουνται για την αντιμετωπιση του hiv
CY1121418T1 (el) Παρεμποδιστες ιου ηπατιτιδας c
CY1122695T1 (el) Αλας toy omecamtiv mecarbil και διαδικασια για την παρασκευη αλατος
CY1121413T1 (el) Διυδροπυρρολοπυριδινης αναστολεις ror-γαμμα
NI201700020A (es) Compuestos de aminopirimidinilo como inhibidores de jak
UY35485A (es) Compuestos heterocíclicos y usos de los mismos
CL2016000468A1 (es) Conjugados anti-dll3 (ligando3 tipo delta) manipulados y métodos de uso.
UY36285A (es) Compuestos que inhiben la proteína mcl-1
CO2018004857A2 (es) Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer
UY35586A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
NI201200191A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
UY35663A (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos
ECSP17007208A (es) Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble
AR081628A1 (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
AR093036A1 (es) Derivados de pirrolotriazinona como inhibidores de pi3k
BR112016012146A2 (pt) Compostos derivados de aminopiridina como inibidores quinase da família tam, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos
AR088828A1 (es) DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3
CO2019006220A2 (es) Compuestos de pirazolopirimidina y métodos de uso de los mismos
UY36124A (es) Derivados de carboxamida
AR098723A1 (es) Derivados de pirazolopirimidin-2-ilo como inhibidores de jak
UY35332A (es) Derivados de pirrolotriazina como inhibidores de pi3k
MX2015013224A (es) Inhibidores macrociclicos y biciclicos del virus de la hepatitis c.
UY35087A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
CY1123744T1 (el) Παραγωγα πυριδινυλιου, φαρμακευτικες συνθεσεις και χρησεις αυτων ως αναστολεων aoc3
CL2020001277A1 (es) Derivados de piridinona y su uso como inhibidores selectivos de alk-2.

Legal Events

Date Code Title Description
FB Suspension of granting procedure